China Issues Deepening Health Care Reform Plan To Reign In Drug Prices
This article was originally published in PharmAsia News
Executive Summary
Prices for pharmaceuticals widely used in clinics could be the target of efforts by the Chinese government to curb costs. At the same time, an aggressive move to stamp out kickbacks for drug sales is under way as China’s federal cabinet, or State Council, moves to deepen health care reforms.